Arrowhead Pharmaceuticals Inc. ARWR
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Arrowhead Pharmaceuticals is a biotechnology company focused on developing innovative medicines for intractable diseases. The company specializes in RNA interference (RNAi) therapeutics, a cutting-edge approach to treating genetic and metabolic disorders by targeting disease-causing proteins at the molecular level. Its…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees609
TickerARWR
Statistics
Market Cap$11.49B
Revenue (TTM)$829.4M
Net Income-$1.6M
Net Margin-0.2%
EPS$-0.01
P/E47.10
P/S16.78
P/B16.96
EV/EBITDA-48.59
ROE-42.4%
Dividend Yield—
Price$81.72
Data: Twelve Data · Revenue = mcap / P/S